Table 2.
Characteristics of study subjects included in the analysis of 5-year relative survival: people aged 50–74 years at time of CRC diagnosis during 2004–2019 in Flanders, Belgium (grouped by CRC screening status).
| Screen-Detected CRC (N = 4959) |
FIT-Interval Cancer (N = 905) |
CRC in Never-Invited (N = 25,353) |
FIT Non-Participant CRC (N = 4555) |
|
|---|---|---|---|---|
| Men | 3157 (63.7%) | 468 (51.7%) | 15,298 (60.3%) | 2854 (62.7%) |
| Mean age (years) ± SD | 65.7 ± 5.8 | 66.5 ± 5.4 | 64.4 ± 6.9 | 66.2 ± 5.6 |
| Stage | ||||
| • I | 2532 (51.0%) | 234 (25.9%) | 4352 (17.2%) | 845 (18.6%) |
| • II | 799 (16.1%) | 151 (16.7%) | 5880 (23.2%) | 980 (21.5%) |
| • III | 1185 (23.9%) | 249 (27.5%) | 7325 (28.9%) | 1257 (27.6%) |
| • IV | 325 (6.6%) | 241 (26.6%) | 5723 (22.6%) | 1321 (29.0%) |
| • Unknown | 118 (2.4%) | 30 (3.3%) | 2073 (8.2%) | 152 (3.3%) |
| Mean time between FIT and diagnosis (days) | 77.9 | 425.0 | - | - |
CRC, colorectal cancer; FIT, faecal immunochemical test.